Rituximab offers a new hope for lupus patientsAccording to rheumatologists at the Annual European Congress of Rheumatology in Vienna, Austria, Rituximab that is presently used to treat cancer can also prove its worth when it comes to treating patients with lupus and suffering from complications of the central nervous system.

Lupus is a disorder of the immune system in which the human body attacks itself resulting in pain, inflammation, and diffuse damage to many body organs. Medical studies have proved that lupus can dramatically minimize the life quality of patients to add to the misery.

It was remarked by Professor Neuwelt that Rituximab appears to very efficacious and can be described as a gentler form of treatment capable of lasting up to 6 months with a low risk of any side effects.